Global Tissue Diagnostics Market Outlook: A 6.4 Billion Market by 2026 with CAGR of 6% Forecast During 2021 to 2026 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Tissue Diagnostics: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global tissue diagnostics market should reach $6.4 billion by 2026 from $4.7 billion in 2021 at a compound annual growth rate (CAGR) of 6.0% for the forecast period of 2021 to 2026.

The general culture test segment of the global tissue diagnostics market is expected to grow from $3.0 billion in 2021 to $3.9 billion in 2026 at a CAGR of 5.4% for the forecast period of 2021 to 2026.

The AST/ID test segment of the global tissue diagnostics market is expected to grow from $1.1 billion in 2021 to $1.5 billion in 2026 at a CAGR of 7.1% for the forecast period of 2021 to 2026.

The report analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, South Korea, Taiwan, Africa, Australia, Brazil, and Russia, among others. The report also examines market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the industry through their best practices in the research and development of tissue diagnostic tests. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.

This study will provide information on these areas -

• Structure and current market size of the market for tissue diagnostics as outlined with forecasts through 2026.
• Impact of chronic diseases, growing and aging populations.
• Current technology and product suppliers and key innovations.
• A look at the trends affecting the market.
• Markets by each segment of type of test (general culture test, AST/ID tests and blood culture tests).
• A global overview showing market data for North America, Europe, Asia-Pacific and the Rest of the World.
• Emerging opportunities and potential investment opportunity areas for tissue diagnostics.
• Profiles for more than 20 companies in the industry with significant contributions and market shares.

The Report Includes:

• 107 data tables and 28 additional tables
• An overview of the global market for tissue diagnostic testing
• Estimation of the market size and analyses of the global market trends, with data from 2018 to 2020, estimates for 2021 with a projection of CAGR through 2026
• Market share analysis of tissue diagnostic testing based on type, application, end-user and geography
• A detailed description of the three major tissue diagnostics tests, i.e., hematoxylin and eosin (H&E), immunohistochemistry (IHC) and in situ hybridization (ISH)
• Description of molecular diagnostic tests including antigen tests, antibody (serology) tests and in vitro diagnostic testing, and information on alternative options for diagnostic tests
• Details about the COVID-19 global pandemic, its testing basics and specific tests for the management of COVID-19 patients
• Identification of new opportunities, challenges and technological changes within the industry
• Assessment of regulatory structure, pricing and reimbursement scenario, pipeline analysis and FDA product approvals in 2020
• Company profiles of major players in the market, including Abbott Diagnostics Inc., Becton, Dickinson and Co., General Electric, Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Landscape

• COVID-19 Global Pandemic
• Coronavirus Disease 2019 Testing Basics
• Diagnostic Tests with Alternative Options
• Molecular Diagnostic Tests
• Increasing Access to Testing
• Antigen Tests
• Antibody (Serology) Tests
• In Vitro Diagnostic Testing EUAs
• Diagnostic Tests
• Serology/Antibody Tests
• Tests for the Management of COVID-19 Patients
• Market Overview and Segmentation
• Key Findings
• Factors Influencing the Global Market for Tissue Diagnostics
• Drivers
• Challenges
• Regulatory Landscape
• IVD Regulations

Chapter 4 Global Market for Tissue Diagnostics by Type of Test

• Tissue Diagnostics
• Trends in the Tissue Diagnostic Test Segments
• Blood Culture
• General Cultures (Urine/Saliva/Stool/Sputum/CSF and Other Body Fluids)
• Identification and Antibiotic Susceptibility Testing (ID/AST)
• FDA Product Approvals in 2020

Chapter 5 Global Market for Tissue Diagnostics by Application

Chapter 6 Global Market for Tissue Diagnostics by Region

Chapter 7 Global Market for Tissue Diagnostics by End User/End Use

• End Users/End Uses
• Professional Laboratories
• Emergency Care/Bed Side/OTC/Self-testing

Chapter 8 Competitive Landscape

• Market Share Analysis
• Mergers and Acquisitions
• Product Approvals

Chapter 9 Company Profiles

• Abbott Diagnostics Inc.
• Agilent Technologies Inc.
• Beckman Coulter (Part Of Danaher)
• Becton Dickinson And Co.
• Biomerieux
• Bio-Rad
• General Electric
• F. Hoffmann-La Roche Ltd.
• Hologic Inc.
• Merck Kgaa
• Ortho Clinical Diagnostics
• Qiagen N.V.
• Siemens Healthineers Ag
• Thermo Fisher Scientific

Chapter 10 Appendix: Market Participants and List of Acronyms

For more information about this report visit https://www.researchandmarkets.com/r/k2zszf

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.